Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Thrombolytic (fibrinolytic) agents

3

III.a Alveolar hemorrhage (AH), diffuse AH (DAH)

2
Last update : 20/01/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Alteplase (rTPA)
2
Fibrinolytic agents (intrapleural)
1
Streptokinase
2
Tenecteplase
1
Urokinase
1

Publications

[Alveolar hemorrhage as a complication of thrombolytic therapy].
Medicina 2011;71;547-9 2011
Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism.
The American journal of cardiology 2006 Jan 01;97;127-9 2006 Jan 01
[A diffuse pulmonary hemorrhage following thrombolytic therapy in an acute myocardial infarct].
Revista espanola de cardiologia 1992;45;421-4 1992

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies